Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Interest-Expense" stands at 9.30 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.
Kyowa Kirin Co Ltd's second quarter result of 2.54 Billion JPY for the item "Interest Expense" represents an increase of 1,700.71 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 2.54 Billion JPY for the item "Interest Expense" represents an increase of 248.29 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 9.30 Billion JPY for the item "Interest Expense" represents an increase of 24.16 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 778.28 percent compared to the value the year prior.
The 1 year change in percent is 778.28.
The 3 year change in percent is 88.81.
The 5 year change in percent is 938.06.
The 10 year change in percent is 18,502.00.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Expense | 280,205,508,085.11 |